Transgene SA (EPA:TNG)
0.820
-0.032 (-3.76%)
At close: Mar 6, 2026
Transgene Employees
Transgene had 147 employees as of June 30, 2025. The number of employees increased by 3 or 2.08% since the number was reported on December 31, 2024.
Employees
147
Change
3
Growth
2.08%
Revenue / Employee
€51,531
Profits / Employee
€250,211
Market Cap
224.54M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Cellectis | 222 |
| MaaT Pharma | 65 |
| Innate Pharma | 174 |
| Sensorion | 68 |
| Adocia | 77 |
| Genfit | 188 |
| ABIONYX Pharma | 51 |
| OSE Immunotherapeutics | 64 |
Transgene News
- 4 months ago - Transgene SA (TRGNF) Discusses TG4050 Phase I Immunological Data in Head and Neck Cancer from SITC Presentation Transcript - Seeking Alpha
- 6 months ago - Transgene SA (FRA:TGNA) (Half Year 2025) Earnings Call Highlights: Strategic Focus on TG4050 ... - GuruFocus
- 6 months ago - Half Year 2025 Transgene SA Earnings Call Transcript - GuruFocus
- 6 months ago - Transgene SA 2025 Q2 - Results - Earnings Call Presentation - Seeking Alpha
- 6 months ago - Transgene SA (TRGNF) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 1 year ago - Half Year 2024 Transgene SA Earnings Call Transcript - GuruFocus
- 2 years ago - Transgene SA (TRGNF) Q2 2023 Earnings Call Transcript - Seeking Alpha
- 3 years ago - Transgene Announces New Leadership Structure to Accelerate the Development of its Innovative Immunotherapy Portfolio - Business Wire